New Horizons in the Medical Management of Vasomotor Symptoms

Virtual | Apr 26, 2021

About the Course

In this activity, Nanette F. Santoro, MD, and Hugh S. Taylor, MD, take a close look at vasomotor symptoms (VMS) in menopause. Learn what causes VMS and the tell-tale signs to look for when diagnosing. Also discussed are evidence and indications for medical management options and the latest data on a new class of nonhormonal agents called selective neurokinin-3 receptor antagonists.

This activity is endorsed by the National Menopause Foundation.

National Menopause Foundation Logo

Learning Objectives

After participating in this educational activity, learners should be better able to:

  • Describe endocrinologic changes during menopause that lead to VMS and individual determinants associated with their incidence and severity
  • Discuss data on the healthcare burden associated with VMS symptoms
  • Communicate the risks and benefits of VMS treatments to address barriers to medical management
  • Evaluate the latest clinical trial data on investigational agents for VMS that are nearing approval

Accreditation and Credit Designation Statement 

Global Learning Collaborative is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

Global Learning Collaborative designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Omnia Education

Omnia Education logo